Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Current trial landscape of IgA nephropathy therapy
Jackson Kim1, Fahmeedah Kamal1, Richard Lafayette1
1Department of Nephrology, Stanford Hospital, Stanford University School of Medicine, Stanford, CA 94305, USA.
None:
IgA nephropathy is in a transformative era, with disease-targeted therapies advancing beyond supportive care. This Trial Watch summarizes recent clinical progress in complement inhibition, endothelin receptor antagonism, and B cell and plasma-cell-directed strategies, highlighting promising reductions in proteinuria, preservation of renal function, and the emerging framework for precision, biomarker-guided treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

